 Bennett Jones Education Ryerson University, Ted Rogers School of Management, BComm, 2010 University of Toronto, JD, 2014 Bar Admissions Ontario, 2015 Overview Christopher Travascio is a corporate partner in the Toronto office of Bennett Jones. Christopher regularly advises prominent and emerging private companies, leading private equity sponsors and venture capital firms on a variety of corporate matters, with an emphasis on domestic and cross-border M&A transactions, management and leveraged buyouts, carve-outs, minority investments, joint ventures, shareholder arrangements and other strategic transactions. Christopher's experience in corporate finance includes advising issuers and investment dealers on public and private offerings of debt and equity securities. Christopher acts for clients in a broad range of industries, including software and technology, health care, construction, real estate, and food and beverage. Christopher is involved in a number of community and charitable initiatives, including leading a team of fundraisers and participants in The Princess Margaret's Road Hockey to Conquer Cancer, the world's largest road hockey fundraiser, and the MLSE Team-Up Challenge in support of Camp Trillium and the MLSE Foundation. Christopher is a member of the Canadian Bar Association and the Ontario Bar Association.
Mergers & Acquisitions • Resolve Sleep Health, a portfolio company of Kensington Private Equity Fund, in its acquisition of Aveiro Sleep, CanSleep, Parkland CPAP Services, SleepMedix, Chinook Respiratory Care and FreshAir Respiratory Care • Datasite LLC, a portfolio company of CapVest Partners LLP, in its acquisition of Firmex Inc., a leading virtual data room and subscription file-sharing provider. • Dye & Durham Limited, a leading provider of cloud-based software and technology solutions for legal and business professionals, in its $530-million acquisition of DoProcess LP, an Ontario-based provider of practice-specific software for legal professionals, from OMERS Infrastructure. • Cresco Labs, in its $1.1-billion acquisition of Origin House, the largest public company acquisition in the history of the U.S. cannabis sector. • Resolute Health, a portfolio company of Kensington Private Equity Fund, in its acquisition of Breathe Well Respiratory Clinic • Kensington Capital Partners in its acquisition of ONE9 Capability Labs, the venture capital investment business of ONE9, establishing Kensington as a market leader for investments in National Security technologies, including cybersecurity, and dual use and defense first technologies • ECI Software Solutions, a global provider of cloud-based business management software and services, in its acquisition of Avid Ratings • Minority shareholders of Kensington Capital Partners Ltd., one of Canada’s leading alternative investment firms, in the sale of a majority 51% interest to AGF Management Ltd., a leading Canadian independent asset management firm. • Book4Time in its US$150-million sale to Agilysys • Procuritas, a Swedish private equity firm focused on investing in and growing mid-market companies, in its acquisition of Precision BioLogic Incorporated, leaders in hemostasis diagnostics and research.
• Clearpath Robotics Inc., a leader in autonomous robotics, in its sale to Rockwell Automation, Inc. • Kensington Capital Advisors Inc. in its approximately $148.5-million sale of its majority interest in Ace Beverage Group Inc. to Corby Spirit and Wine Limited. • HRSoft, the global leader for cloud-based Compensation Lifecycle Management software, in its acquisition of CompTrak Inc., a compensation management solution provider. • Kensington Capital Partners and Kensington Private Equity Fund in its acquisition and subsequent amalgamation of Resolute Health Corporation Limited, a leading Canadian healthcare services business specializing in the testing and treatment of obstructive sleep apnea. • Kensington Capital Partners and Kensington Private Equity Fund, in its acquisition of Chirurgie DIX30 Inc. and Medego Immobilier Inc., a specialized medical and surgical centre in Brossard, Quebec. • Kensington Capital Partners and Kensington Private Equity Fund in its majority equity investment in Jewlr and its affiliate, Safyre Labs, both direct-to-consumer ecommerce retailers specializing in the design and manufacturing of personalized and custom jewelry. • Uncata Inc., a provider of 1-to-1 digital solutions for grocers, in its acquisition by Instacart. • TELUS Corporation, in numerous private, technology-focused, M&A acquisitions throughout Canada and the United States. • Kensington Capital Partners and Kensington Private Equity Fund, in the $35-million acquisition and related financing through its portfolio company, Clearpoint Health Network Inc., of the surgical and medical centres business of Centric Health Corporation, a TSX listed company, and subsequent reorganization of Clearpoint. Kensington Capital Advisors Inc. is a leading independent investor in alternative assets with over $1.5 billion invested in private equity and alternative assets. • Cresco Labs Inc., in its acquisition of Tryke Companies, including the Reef Dispensary Portfolio, for US$252.5 million for Tryke operating assets plus US$30 million for Tryke real estate assets. • Brainlabs, a portfolio investment of Livingbridge and a leading data-led marketing agency, in its acquisition of Canadian programmatic buying and Google marketing platform consultants, MediaNet. • ECI Software Solutions, in its acquisition of Shoptech Industrial Software Corp., a provider of ERP software for job shops and made-to-order manufacturers. • Institutional investors advised by JP Morgan Asset Management in the acquisition of Contanda, a provider of bulk liquid storage and logistics services, from EQT Infrastructure II Fund • ECi Software Solutions Inc., in its acquisition of Print Audit. • ECi Software Solutions Inc., in its acquisition of Lasso Data Systems. • ECi Software Solutions Inc., a leader in industry-specific information technology solutions, in its acquisition of PrintFleet Inc. • Toronto-based FlashStock Technology Inc., in its sale to Shutterstock, Inc., a leading global provider of commercial digital imagery, for approximately US$50 million. • Special Committee of Halogen Software Inc., in a $293-million acquisition by way of plan of arrangement. • Fluorinov Pharma Inc., a privately-held oncology company, in its $10-million acquisition by Trillium Therapeutics Inc. • Connected Lab Inc. in its acquisition by Thoughtworks, Inc. Securities • A syndicate of agents led by Canaccord Genuity in a C$11.5-million “best efforts” brokered private placement of unsecured convertible debentures of Hydreight Technologies • A syndicate of agents led by Canaccord Genuity in a C$9-million LIFE offering of Units of NTG Clarity Networks • A syndicate of underwriters led by Canaccord Genuity in a C$11.5-million LIFE offering of common shares of Gatekeeper Systems • HASSLACHER Group, a globally active innovation leader in the field of intelligent and integrated system solutions for modern timber construction, as Canadian Counsel in its significant investment in Element5, a mass timber manufacturer. • Cresco Labs LLC, in its $2.2-billion reverse takeover transaction and public listing on the Canadian Securities Exchange. • Clearpath Robotics, in numerous matters, including financings that included Canadian and U.S.-based venture capital investors, and its credit facility with Silicon Valley Bank • Canaccord Genuity, as sole agent and bookrunner, in its brokered private placement of units of NTG Clarity Networks • Eight Capital in its brokered private placement of units and flow-through units of Bonterra Resources Inc. for aggregate gross proceeds of approximately $8.5-million. • Canaccord Genuity Corp., as sole agent and sole bookrunner, in the brokered treasury and secondary private placement of common shares of BET99 (Sports Venture Holdings Inc.) for aggregate gross proceeds of $15.5 million. • District Ventures, in formation of venture capital fund and fund investments in companies in the consumer packaged goods industry. • Canaccord Genuity Corp., as sole bookrunner and lead underwriter, in connection with the $4.5-million overnight marketed public offering of 10,000,000 units of Nepra Foods Inc. • Canaccord Genuity Corp., on its behalf and on behalf of a syndicate of underwriters, in the pre-RTO brokered private placement of subscription receipts of Liquid Meta Capital Holdings Ltd. for aggregate gross proceeds of approx. US$20 million. • Canaccord Genuity Corp., in an up to $10-million at-the-market equity program for the sale of common shares pursuant to an equity distribution agreement with Tetra-Bio Pharma Inc. (TSX: TBP, OTCQX: TBPMF). • Canaccord Genuity Corp., as sole agent and sole bookrunner, in the oversubscribed $7.47 million initial public offering of common shares of Nepra Foods Inc. (CSE: NPRA). • Canaccord Genuity Corp., on its behalf and on behalf of a syndicate of underwriters, in the bought deal public offering of units of QuestCap Inc. for gross proceeds of $5 million. • Clearpath Robotics, in numerous matters, including financings that included Canadian and U.S.-based venture capital investors, and its credit facility with Silicon Valley Bank. • Canaccord Genuity Corp., on its behalf and on behalf of a syndicate of underwriters, in the bought deal public offering of units of ESE Entertainment Inc. for gross proceeds of $8.6-million. • Canaccord Genuity Corp., on its behalf and on behalf of a syndicate of underwriters, in the “bought deal” private placement of units of GameSquare Esports Inc. for gross proceeds of $8.5-million. • Canaccord Genuity Corp., as sole agent and sole bookrunner, in the brokered private placement of units of Medivolve Inc. for aggregate gross proceeds of $5 million. • Canaccord Genuity Corp., as lead agent, in the brokered private placement of units and flow-through shares of NioBay Metals Inc. for aggregate gross proceeds of $11.5 million. • Cresco Labs Inc., in a public offering of 7,350,000 units at a price per unit of $10.00 for gross proceeds of $73,500,000. • District Ventures, in its equity investment in seven companies as part of its accelerator program. • Gold Flora, LLC, in its private placement offering of debenture units for aggregate gross proceeds of over US$14 million. • TerrAscend Corp., in its non-brokered private placement of common shares for aggregate gross proceeds of approximately $69 million. • A syndicate of agents, led by Canaccord Genuity Corp., in the brokered private placement of units of LiveWell Foods Canada Inc. for aggregate gross proceeds of $10 million. • Canaccord Genuity Corp., as sole agent and sole bookrunner, in the brokered private placement of special warrants of CLS Holdings USA, Inc. for aggregate gross proceeds of $13 million. • Canaccord Genuity Corp., as sole agent and sole bookrunner, in the brokered private placement of convertible debentures of Central Coast Agriculture, Inc. for aggregate gross proceeds of up to US$25 million. • A syndicate of agents, led by Canaccord Genuity Corp., in the brokered private placement of convertible debentures of CLS Holdings USA, Inc. for aggregate gross proceeds of up to US$20 million. • Opus One Energy Solutions, in a financing by two U.S.-based venture capital investors. • Clearpath Robotics, in numerous matters, including financings that included Canadian and U.S.-based venture capital investors. • Book4Time, in financing matters. • OMERS Ventures LP, in its participation in the $6 million Series A funding round of Fusebill Inc. • Park Lawn Corporation, in the $24.2-million bought deal prospectus offering of 2,105,400 subscription receipts in December, 2015 - Counsel to syndicate of underwriters led by National Bank Financial Inc. |